Employers continue to purchase stop-loss insurance -- and for good reason. The number of claims $1.5 million and above rose 54% between 2015 and 2018. And the number of $3M plus claimants doubled just last year alone. With costly gene therapies and other specialty drugs on the rise, employers can only expect to see multi-million-dollar claims with greater frequency.
Is your company taking unnecessary risks with its health dollars?
Discussion topics include:
HR managers and above for small to mid-size companies across the Midwest